elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33689457-4909326C-B226-4752-9B0E-FC00A8A85459
Q33689457-4909326C-B226-4752-9B0E-FC00A8A85459
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33689457-4909326C-B226-4752-9B0E-FC00A8A85459
A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC.
P2860
Q33689457-4909326C-B226-4752-9B0E-FC00A8A85459
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33689457-4909326C-B226-4752-9B0E-FC00A8A85459
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d577f7220d3185a810fc64ab11cb999b0fef0491
P2860
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer